Company Filing History:
Years Active: 2006-2013
Title: Innovator Ying-Xin Zhang: Pioneering Research in Cell and Organism Evolution
Introduction
Ying-Xin Zhang, an accomplished inventor based in Redwood City, California, has made significant contributions to the fields of synthetic biology and genetic engineering. With a portfolio that boasts four patents, she stands out as a leading figure in her area of expertise, particularly through her innovative work with whole cells and organisms.
Latest Patents
Among her notable patents is the groundbreaking invention titled "Evolution of Whole Cells and Organisms by Recursive Sequence Recombination." This invention outlines methods that utilize iterative cycles of recombination and selection/screening to facilitate the evolution of whole cells and organisms toward acquiring desired properties. Examples of these innovative properties include enhanced recombinogenicity, increased genome copy number, and the capacity for expression and/or secretion of proteins and secondary metabolites. This patented technology showcases her ability to push the boundaries of biological research and engineering.
Career Highlights
Ying-Xin Zhang has a rich professional history, having worked with prominent companies such as Maxygen, Inc. and Codexis Mayflower Holdings, LLC. Her tenure at these companies has allowed her to apply her inventive skills in real-world applications, advancing the capabilities of biotechnology and synthetic biology.
Collaborations
Throughout her career, Zhang has collaborated with esteemed professionals such as Stephen DelCardayre and Matthew B Tobin. These collaborations have fostered an environment of innovation, allowing for the exchange of ideas and the development of cutting-edge technologies that pave the way for future discoveries.
Conclusion
Ying-Xin Zhang exemplifies the spirit of innovation through her impressive body of work in the evolution of cells and organisms. Her contributions have not only enriched the scientific community but also opened new avenues for research and application in biotechnology. As she continues to build on her legacy through her patents and professional collaborations, the impact of her work remains significant in shaping the future of synthetic biology.